Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases

Fabio Medas, Gian Luigi Canu, Federico Cappellacci, Francesco Boi, Maria Letizia Lai, Enrico Erdas, Pietro Giorgio Calò, Fabio Medas, Gian Luigi Canu, Federico Cappellacci, Francesco Boi, Maria Letizia Lai, Enrico Erdas, Pietro Giorgio Calò

Abstract

Introduction: Papillary thyroid microcarcinoma (PTMC) is defined as a tumor with a larger diameter ≤ 1 cm and is considered having an indolent course and an excellent prognosis. Nevertheless, the incidence of lymph node metastasis in PTMC is not negligible, reaching up to 65% in some series. The aim of this study was to assess the incidence of lymph node metastasis in patients with PTMC and to evaluate predictive factors for lymph node metastasis. Methods: We included in this retrospective observational study patients who underwent thyroidectomy with pathological diagnosis of PTMC at our department from January 2003 to June 2019. Results: Two hundred ninety-three patients were included in the study. The incidence of lymph node metastasis was 13.7%. Multivariate analysis revealed as independent risk factors for lymph node metastasis age <45 years, nodule size ≥6 mm, tall cell variant of PTC, extrathyroidal extension, and angioinvasion. Conversely, autoimmune thyroiditis was found as a protective factor for lymph node metastasis. A subgroup of patients, with nodule size ≤ 5 mm, presented non-aggressive features. Conclusion: The incidence of lymph node metastasis in PTMC is considerable; the size of the tumor appears to be the most significant predictive factor for lymph node metastasis. The traditional cut-off value used for definition of microcarcinoma could be reconsidered to identify patients with an indolent course of the tumor, where active surveillance could be the appropriate treatment, and on the other hand, patients with potentially aggressive tumors requiring an adequate surgical intervention. Clinical Trial Registration: The trial was registered at ClinicalTrials.gov (ID: NCT04274829).

Keywords: lymph node dissection; lymph node metastasis; microcarcinoma; thyroid carcinoma; thyroidectomy.

Copyright © 2020 Medas, Canu, Cappellacci, Boi, Lai, Erdas and Calò.

Figures

Figure 1
Figure 1
Scatter diagram reporting correlation between tumor size and lymph node ratio. Correlation coefficient = 0.2409; CI = 0.1134–0.3606; p-value = 0.0003.

References

    1. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. (2013) 2013:965212. 10.1155/2013/965212
    1. Ward EM, Jemal A, Chen A. Increasing incidence of thyroid cancer: is diagnostic scrutiny the sole explanation? Future Oncol. (2010) 6:185–8. 10.2217/fon.09.161
    1. Cramer JD, Fu P, Harth KC, Margevicius S, Wilhelm SM. Analysis of the rising incidence of thyroid cancer using the surveillance, epidemiology and end results national cancer data registry. Surgery. (2010) 148:1147–52; discussion 1152–53. 10.1016/j.surg.2010.10.016
    1. Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer. (1989) 63:908–11. 10.1002/1097-0142(19890301)63:5<908::aid-cncr2820630520>;2-i
    1. Schönberger J, Marienhagen J, Agha A, Rozeboom S, Bachmeier E, Schlitt H, et al. . Papillary microcarcinoma and papillary cancer of the thyroid ≤ 1 cm: modified definition of the WHO and the therapeutic dilemma. Nuklearmedizin. (2007) 46:115–20; quiz N41–42. 10.1160/nukmed-0059
    1. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. . 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. (2016) 26:1–133. 10.1089/thy.2015.0020
    1. Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto Y. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg. (2010) 34:1222–31. 10.1007/s00268-009-0359-x
    1. Wada N, Duh Q-Y, Sugino K, Iwasaki H, Kameyama K, Mimura T, et al. . Lymph node metastasis from 259 papillary thyroid microcarcinomas. Ann Surg. (2003) 237:399–407. 10.1097/01.SLA.0000055273.58908.19
    1. Roh J-L, Kim J-M, Park CI. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence. Ann Surg Oncol. (2011) 18:2245–50. 10.1245/s10434-011-1600-z
    1. So YK, Son Y-I, Hong SD, Seo MY, Baek C-H, Jeong H-S, et al. . Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections. Surgery. (2010) 148:526–31. 10.1016/j.surg.2010.01.003
    1. Calò PG, Conzo G, Raffaelli M, Medas F, Gambardella C, De Crea C, et al. . Total thyroidectomy alone versus ipsilateral versus bilateral prophylactic central neck dissection in clinically node-negative differentiated thyroid carcinoma. A retrospective multicenter study. Eur J Surg Oncol. (2017) 43:126–32. 10.1016/j.ejso.2016.09.017
    1. Sheng L, Shi J, Han B, Lv B, Li L, Chen B, et al. Predicting factors for central or lateral lymph node metastasis in conventional papillary thyroid microcarcinoma. Am J Surg. (2019) 220:334–40. 10.1016/j.amjsurg.2019.11.032
    1. Gu J-H, Zhao Y-N, Xie R-L, Xu W-J, You D-L, Zhao Z-F, et al. . Analysis of risk factors for cervical lymph node metastasis of papillary thyroid microcarcinoma: a study of 268 patients. BMC Endocr Disord. (2019) 19:124. 10.1186/s12902-019-0450-8
    1. Medas F, Canu GL, Boi F, Lai ML, Erdas E, Calò PG. Predictive factors of recurrence in patients with differentiated thyroid carcinoma: a retrospective analysis on 579 patients. Cancers (Basel). (2019) 11:1230. 10.3390/cancers11091230
    1. Calò PG, Medas F, Loi G, Erdas E, Pisano G, Nicolosi A. Differentiated thyroid cancer in the elderly: our experience. Int J Surg. (2014) 12:S140–3. 10.1016/j.ijsu.2014.08.362
    1. Chow S-M, Law SCK, Chan JKC, Au S-K, Yau S, Lau W-H. Papillary microcarcinoma of the thyroid? Prognostic significance of lymph node metastasis and multifocality. Cancer. (2003) 98:31–40. 10.1002/cncr.11442
    1. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, et al. . Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg. (2004) 28:498–501. 10.1007/s00268-004-7192-z
    1. Xiangqian Z, Chen P, Ming G, Jingtai Z, Xiukun H, Jingzhu Z, et al. . Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients. Cancer Biol Med. (2019) 16:121. 10.20892/j.issn.2095-3941.2018.0125
    1. Cheng F, Chen Y, Zhu L, Zhou B, Xu Y, Chen Y, et al. . Risk factors for cervical lymph node metastasis of papillary thyroid microcarcinoma: a single-center retrospective study. Int J Endocrinol. (2019) 2019:1–6. 10.1155/2019/8579828
    1. Kim SK, Park I, Woo J-W, Lee JH, Choe J-H, Kim J-H, et al. . Predictive factors for lymph node metastasis in papillary thyroid microcarcinoma. Ann Surg Oncol. (2016) 23:2866–73. 10.1245/s10434-016-5225-0
    1. Lombardi CP, Bellantone R, De Crea C, Paladino NC, Fadda G, Salvatori M, et al. . Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area. World J Surg. (2010) 34:1214–21. 10.1007/s00268-009-0375-x
    1. Park JP, Roh J-L, Lee JH, Baek JH, Gong G, Cho K-J, et al. . Risk factors for central neck lymph node metastasis of clinically noninvasive, node-negative papillary thyroid microcarcinoma. Am J Surg. (2014) 208:412–8. 10.1016/j.amjsurg.2013.10.032
    1. Xu Y, Xu L, Wang J. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution. J Surg Res. (2018) 221:128–34. 10.1016/j.jss.2017.08.007
    1. Wang M, Wu W-D, Chen G-M, Chou S-L, Dai X-M, Xu J-M, et al. . Could tumor size be a predictor for papillary thyroid microcarcinoma: a retrospective cohort study. Asian Pac J Cancer Prev. (2015) 16:8625–8. 10.7314/apjcp.2015.16.18.8625
    1. Gong Y, Li G, Lei J, You J, Jiang K, Li Z, et al. . A favorable tumor size to define papillary thyroid microcarcinoma: an analysis of 1176 consecutive cases. Cancer Manag Res. (2018) 10:899–906. 10.2147/CMAR.S154135
    1. Choi JB, Lee WK, Lee SG, Ryu H, Lee CR, Kang SW, et al. . Long-term oncologic outcomes of papillary thyroid microcarcinoma according to the presence of clinically apparent lymph node metastasis: a large retrospective analysis of 5,348 patients. Cancer Manag Res. (2018) 10:2883–91. 10.2147/CMAR.S173853
    1. Oh H-S, Ha J, Kim HI, Kim TH, Kim WG, Lim D-J, et al. . Active surveillance of low-risk papillary thyroid microcarcinoma: a multi-center cohort study in Korea. Thyroid. (2018) 28:1587–94. 10.1089/thy.2018.0263
    1. Zhao H, Li H. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: diagnosis of central and lateral compartment nodal metastases. Eur J Radiol. (2019) 112:14–21. 10.1016/j.ejrad.2019.01.006
    1. Xue S, Wang P, Hurst ZA, Chang YS, Chen G. Active surveillance for papillary thyroid microcarcinoma: challenges and prospects. Front Endocrinol (Lausanne). (2018) 9:736. 10.3389/fendo.2018.00736
    1. Wen X, Wang B, Jin Q, Zhang W, Qiu M. Thyroid antibody status is associated with central lymph node metastases in papillary thyroid carcinoma patients with Hashimoto's thyroiditis. Ann Surg Oncol. (2019) 26:1751–8. 10.1245/s10434-019-07256-4
    1. Vasileiadis I, Boutzios G, Charitoudis G, Koukoulioti E, Karatzas T. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma. Ann Surg Oncol. (2014) 21:2725–32. 10.1245/s10434-014-3593-x
    1. Karatzas T, Vasileiadis I, Zapanti E, Charitoudis G, Karakostas E, Boutzios G. Thyroglobulin antibodies as a potential predictive marker of papillary thyroid carcinoma in patients with indeterminate cytology. Am J Surg. (2016) 212:946–52. 10.1016/j.amjsurg.2015.12.030
    1. Paparodis R, Imam S, Todorova-Koteva K, Staii A, Jaume JC. Hashimoto's thyroiditis pathology and risk for thyroid cancer. Thyroid. (2014) 24:1107–14. 10.1089/thy.2013.0588

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться